CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +180,632 | 180,632 | ||
| 2025-06-13 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +135,092 | 135,092 | ||
| 2024-06-11 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +98,607 | 98,607 | ||
| 2024-03-01 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +100,000 | 100,000 | ||
| 2024-02-20 | Dukes Iain D. Director | Purchase | +32,000 | $9.15 | $293K | 54,000 |
| 2023-06-06 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +103,911 | 103,911 | ||
| 2022-11-23 | Dukes Iain D. Director | Purchase | +10,000 | $6.10 | $61K | 22,000 |
| 2022-06-10 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +102,409 | 102,409 | ||
| 2021-06-29 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2020-06-08 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 |
Page 1 of 1 · 10 trades